President-elect Donald Trump held a 90-minute meeting on Thursday with U.S. President Barack Obama in the White House to discuss the transition of power after the Republican’s stunning election victory.
Sitting next to the Democratic president in the Oval Office, Trump told reporters: “We really discussed a lot of situations, some wonderful, some difficulties.” He said Obama explained “some of the great things that have been achieved,” but did not elaborate.
Trump, elected on Tuesday to his first public office, said he looked forward to more meetings with Obama.
Obama said he will do everything he can to help the New York businessman succeed when he takes office on Jan. 20 and urged the country to unite to face its challenges.
“My number-one priority in the coming two months is to try to facilitate a transition that ensures our president-elect is successful,” Obama said at the end of the meeting.
(Reporting by Roberta Rampton, Steve Holland and Jeff Mason; Writing by Richard Cowan; Editing by Alistair Bell)
— ABC News Politics (@ABCPolitics) November 10, 2016
Democrats and Never-Trumpers gaming out ‘doomsday scenarios’ if president refuses to leave office: report
According to a report in the New York Times, Democratic strategists and Never-Trumper conservatives fear Donald Trump will refuse to leave office should he lose in November and are making plans and figuring out their legal options should such an unprecedented state of affairs come to pass.
The report, by the Times' Reid Epstein, begins with one such possible scenario.
‘Retaliation plain and simple’: Vaccine agency top Doc fired by Trump administration files whistleblower complaint
Dr. Rick Bright has retained an attorney and will be filing a whistleblower complaint after the Trump administration fired him from his position as head of the federal agency charged with developing a COVID-19 vaccine. Dr. Bright was moved to a different agency with a narrower focus after he raised concerns over President Donald Trump's obsession with promoting hydroxychloroquine, a malaria drug recent studies found doubles the death rate in coronavirus patients.
Checking blood for coronavirus antibodies – 3 questions answered about serological tests and immunity
Coronavirus testing in the United States is moving into a new phase as scientists begin looking into people’s blood for signs they’ve been infected by SARS-CoV-2, the virus that causes COVID-19. This technique is called serological testing.
Virologist Daniel Stadlbauer helped develop a serological test to detect SARS-CoV-2 antibodies and helped transfer it from the research lab to the clinical setting. Epidemiologist Aubree Gordon regularly uses serological assays in her research studies on influenza and dengue fever. She’s now established serological testing for SARS-CoV-2 in her research lab.